Peripheral neuropathy independently associated with mortality risk: Study
There is growing evidence indicates that peripheral neuropathy (PN) is common even in the absence of diabetes. However, its clinical sequelae has not been quantified in the general population.
A recent study published in the Annals of Internal Medicine on 8 December 2020 suggests, Peripheral neuropathy was associated with mortality in the US population regardless of diabetes status, which implies screening for Peripheral neuropathy may be important for older adults both with and without diabetes.
The American Diabetes Association has issued multiple recommendation statements about diabetic neuropathies and the care of the diabetic foot. Given that approximately 50% of adults with diabetes will be affected by peripheral neuropathy in their lifetime, more diligent screening and management are important to reduce the complications and health care burden associated with the disease. Peripheral neuropathy (PN) is common in the general US adult population, especially in older adults even in the absence of diabetes. However, the clinical sequelae of Peripheral Neuropathy (PH) have not been quantified in the general population. Researchers of Baltimore assessed the associations of prevalent PN with all-cause and cardiovascular mortality using data from the National Health and Nutrition Examination Survey(NHANES) 1999 to 2004.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.